Live from the NIH registry
Studies recruiting near Fayetteville right now
Top 25 of 121 recruiting studies, sorted by proximity — each links to its official registry page
ERP to Improve Functioning in Veterans With OCD
Obsessive Compulsive Disorder (OCD), Comorbid Post-Traumatic Stress Disorder and OCD
N/A
Interventional 160 participants sought
Fayetteville VA Medical Center, Fayetteville, NC — Fayetteville, North Carolina (6.0 mi)
· Sponsor: VA Office of Research and Development
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Pancreatic Cancer, Pancreatic Cancer Metastatic
Phase 3
Interventional 570 participants sought
FirstHealth of the Carolinas — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Immuneering Corporation
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus
Phase 2
Interventional 405 participants sought
Cross Creek Medical Clinic, PA — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Boehringer Ingelheim
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Ovarian Cancer, Fallopian Tube Cancer
Phase 3
Interventional 770 participants sought
FirstHealth Cancer Center ( Site 0079) — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi)
· Sponsor: SWOG Cancer Research Network
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Hoffmann-La Roche
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Pinehurst Medical Clinic, Inc. - East — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Boehringer Ingelheim
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Obesity, Overweight
Phase 3
Interventional 3,600 participants sought
ACCOMPLISH-1 Research Site — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
Advanced Extrapulmonary Neuroendocrine Carcinoma, Metastatic Extrapulmonary Neuroendocrine Carcinoma
Phase 2, Phase 3
Interventional 189 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi)
· Sponsor: National Cancer Institute (NCI)
Comparative Performance of a Vaginal Yeast Test
Vulvovaginal Candidiasis
N/A
Observational 1,200 participants sought
Womack Army Medical Center — Fort Bragg, North Carolina (4.1 mi)
· Sponsor: Uniformed Services University of the Health Sciences
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 2,400 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi)
· Sponsor: SWOG Cancer Research Network
Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital
Phase 3
Interventional 400 participants sought
Cross Creek Medical Clinic, PA — Fayetteville, North Carolina (6.0 mi)
· Sponsor: pH-D Feminine Health LLC
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Breast Cancer
N/A
Observational 1,800 participants sought
FirstHealth Outpatient Cancer Center — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Exact Sciences Corporation
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis, Non-alcoholic Fatty Liver Disease
Phase 2
Interventional 42 participants sought
GSK Investigational Site — Fayetteville, North Carolina (6.0 mi)
· Sponsor: GlaxoSmithKline
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Cervical Cancer
N/A
Interventional 840 participants sought
FirstHealth Outpatient Cancer Center — Pinehurst, North Carolina (28.8 mi)
· Sponsor: GOG Foundation
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
Excessive Sleepiness, Shift-work Disorder
Phase 3
Interventional 520 participants sought
Clinical Research Site — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Axsome Therapeutics, Inc.
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Phase 3
Interventional 830 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Canadian Cancer Trials Group
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Javara Inc. — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Duke University
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,250 participants sought
Research Site — Fayetteville, North Carolina (6.0 mi)
· Sponsor: AstraZeneca
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Bronchiectasis
Phase 3
Interventional 1,755 participants sought
Pinehurst Medical Clinic, Inc. - East — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Boehringer Ingelheim
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma
Phase 3
Interventional 382 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 1,524 participants sought
FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver Fibrosis
Phase 3
Interventional 1,800 participants sought
Coastal Research Institute, LLC — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Boehringer Ingelheim
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Proteinuric Kidney Disease
Phase 2
Interventional 74 participants sought
Research Site — Fayetteville, North Carolina (6.0 mi)
· Sponsor: Maze Therapeutics